SELINCRO 18 mg, film-coated tablet 14 tablets
Active ingredients: Nalmefene hydrochloride dihydrate, Nalmefene
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SELINCRO 18 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 14 comprimé(s)
- Marketing authorisation holder
- LUNDBECK (DANEMARK)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Feb 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63957761CIP72744348CIP133400927443480Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NALMÉFÈNEcomprimé | 18,06 mg · un comprimé | FT |
| CHLORHYDRATE DE NALMÉFÈNE DIHYDRATÉcomprimé | 21,917 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.